258 related articles for article (PubMed ID: 32083087)
1. Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study.
Liang J; Cao H; Ke Y; Sun C; Chen W; Lin J
Front Med (Lausanne); 2020; 7():12. PubMed ID: 32083087
[No Abstract] [Full Text] [Related]
2. Hemophagocytic Lymphohistiocytosis: Prevalence, Risk Factors, Outcome, and Outcome-related Factors in Adult Idiopathic Inflammatory Myopathies.
Liang J; Xu D; Sun C; Chen W; Cao H; Lin J
J Rheumatol; 2020 Oct; 47(10):1532-1540. PubMed ID: 31575703
[TBL] [Abstract][Full Text] [Related]
3. Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model.
Cao H; Huan C; Wang Q; Xu G; Lin J; Zhou J
Rheumatol Ther; 2020 Dec; 7(4):967-978. PubMed ID: 33106937
[TBL] [Abstract][Full Text] [Related]
4. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
5. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
6. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.
Liang J; Cao H; Yang Y; Ke Y; Yu Y; Sun C; Yue L; Lin J
Front Med (Lausanne); 2021; 8():626953. PubMed ID: 33614683
[No Abstract] [Full Text] [Related]
8. HRCT findings predict 1-year mortality in patients with acute exacerbation of idiopathic inflammatory myopathies-associated interstitial lung disease.
Zhang J; He L; Han T; Tong J; Ren J; Pu J; Zhang M; Guo Y; Jin C
Heliyon; 2024 Jun; 10(11):e31510. PubMed ID: 38841458
[TBL] [Abstract][Full Text] [Related]
9. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
[TBL] [Abstract][Full Text] [Related]
10. Fever in the initial stage of IIM patients: an early clinical warning sign for AE-ILD.
Liu T; Chen H; Shi Y; Xu W; Yuan F
Adv Rheumatol; 2023 Jul; 63(1):31. PubMed ID: 37443073
[TBL] [Abstract][Full Text] [Related]
11. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
13. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
Kastrati K; Nakuz TS; Kulterer OC; Geßl I; Simader E; Mrak D; Bonelli M; Kiener HP; Prayer F; Prosch H; Aletaha D; Langsteger W; Traub-Weidinger T; Blüml S; Lechner-Radner H; Hacker M; Mandl P
EClinicalMedicine; 2024 Jun; 72():102598. PubMed ID: 38633577
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2021 May; 21(1):150. PubMed ID: 33952218
[TBL] [Abstract][Full Text] [Related]
16. Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies.
Sun F; Zhao J; Li Y; Wang H; Cao X; Cheng W; Chen J
Int Immunopharmacol; 2023 Feb; 115():109609. PubMed ID: 36577160
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
[TBL] [Abstract][Full Text] [Related]
18. Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease.
Chen F; Jin Q; Zhang Y; Wang G; Li G; Shu X
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580342
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.
Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD
Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
